RD-Connect, NeurOmics and EURenOmics: collaborative European initiative for rare diseases

Although individually uncommon, rare diseases (RDs) collectively affect 6–8% of the population. The unmet need of the rare disease community was recognized by the European Commission which in 2012 funded three flagship projects, RD-Connect, NeurOmics, and EURenOmics, to help move the field forward with the ambition of advancing -omics research and data sharing at their core in line with the goals of IRDiRC (International Rare Disease Research Consortium). NeurOmics and EURenOmics generate -omics data and improve diagnosis and therapy in rare renal and neurological diseases, with RD-Connect developing an infrastructure to facilitate the sharing, systematic integration and analysis of these data. Here, we summarize the achievements of these three projects, their impact on the RD community and their vision for the future. We also report from the Joint Outreach Day organized by the three projects on the 3rd of May 2017 in Berlin. The workshop stimulated an open, multi-stakeholder discussion on the challenges of the rare diseases, and highlighted the cross-project cooperation and the common goal: the use of innovative genomic technologies in rare disease research.

[1]  Morris A. Swertz,et al.  Beyond standardization: dynamic software infrastructures for systems biology , 2007, Nature Reviews Genetics.

[2]  Jan-Eric Litton,et al.  Biobanking for Europe , 2007, Briefings Bioinform..

[3]  C. Béroud,et al.  Human Splicing Finder: an online bioinformatics tool to predict splicing signals , 2009, Nucleic acids research.

[4]  Christophe Béroud,et al.  UMD‐predictor, a new prediction tool for nucleotide substitution pathogenicity—application to four genes: FBN1, FBN2, TGFBR1, and TGFBR2 , 2009, Human mutation.

[5]  Morris A. Swertz,et al.  The MOLGENIS toolkit: rapid prototyping of biosoftware at the push of a button , 2010, BMC Bioinformatics.

[6]  G. Biella,et al.  Human Pluripotent Stem Cell Differentiation into Authentic Striatal Projection Neurons , 2013, Stem Cell Reviews and Reports.

[7]  Michael Brudno,et al.  PhenoTips: Patient Phenotyping Software for Clinical and Research Use , 2013, Human mutation.

[8]  Matteo Trudu,et al.  Common noncoding UMOD gene variants induce salt-sensitive hypertension and kidney damage by increasing uromodulin expression , 2013, Nature Medicine.

[9]  F. Anglani,et al.  Characterization of 28 novel patients expands the mutational and phenotypic spectrum of Lowe syndrome , 2015, Pediatric Nephrology.

[10]  K. Tory,et al.  Genotype-phenotype associations in WT1 glomerulopathy. , 2014, Kidney international.

[11]  Orion J. Buske,et al.  The Matchmaker Exchange: A Platform for Rare Disease Gene Discovery , 2015, Human mutation.

[12]  Simon Woods,et al.  International Charter of principles for sharing bio-specimens and data , 2014, European Journal of Human Genetics.

[13]  Francesco Muntoni,et al.  The EuroBioBank Network: 10 years of hands-on experience of collaborative, transnational biobanking for rare diseases , 2014, European Journal of Human Genetics.

[14]  A. Anarat,et al.  Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort. , 2015, Clinical journal of the American Society of Nephrology : CJASN.

[15]  Nimrod Miller,et al.  Motor neuron mitochondrial dysfunction in spinal muscular atrophy. , 2016, Human molecular genetics.

[16]  G. Remuzzi,et al.  Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome. , 2016, Molecular immunology.

[17]  P. Holmans,et al.  RNA-Seq of Huntington’s disease patient myeloid cells reveals innate transcriptional dysregulation associated with proinflammatory pathway activation , 2016, Human molecular genetics.

[18]  Christophe Béroud,et al.  UMD‐Predictor: A High‐Throughput Sequencing Compliant System for Pathogenicity Prediction of any Human cDNA Substitution , 2016, Human mutation.

[19]  O. Gribouval,et al.  ADCK4-Associated Glomerulopathy Causes Adolescence-Onset FSGS. , 2016, Journal of the American Society of Nephrology : JASN.

[20]  Alexandros Kanterakis,et al.  ePGA: A Web-Based Information System for Translational Pharmacogenomics , 2016, PloS one.

[21]  D. Kahila,et al.  Observations of a large Dent disease cohort. , 2016, Kidney international.

[22]  H. van Attikum,et al.  Antisense oligonucleotide-mediated exon skipping as a strategy to reduce proteolytic cleavage of ataxin-3 , 2016, Scientific Reports.

[23]  Erik Schultes,et al.  The FAIR Guiding Principles for scientific data management and stewardship , 2016, Scientific Data.

[24]  M. Konrad,et al.  Autosomal-Recessive Mutations in SLC34A1 Encoding Sodium-Phosphate Cotransporter 2A Cause Idiopathic Infantile Hypercalcemia. , 2016, Journal of the American Society of Nephrology : JASN.

[25]  A. Elmacı,et al.  Follow-up results of patients with ADCK4 mutations and the efficacy of CoQ10 treatment , 2017, Pediatric Nephrology.

[26]  C. Austin,et al.  The International Rare Diseases Research Consortium: Policies and Guidelines to maximize impact , 2017, European Journal of Human Genetics.

[27]  S. Zubrick,et al.  The collective impact of rare diseases in Western Australia: an estimate using a population-based cohort , 2016, Genetics in Medicine.

[28]  Y. Cam.  EURORDIS-Rare Diseases Europe , 2017 .

[29]  P. Gipson,et al.  The Phenotypic Spectrum of Nephropathies Associated with Mutations in Diacylglycerol Kinase ε. , 2017, Journal of the American Society of Nephrology : JASN.

[30]  A. Anarat,et al.  Long-Term Outcome of Steroid-Resistant Nephrotic Syndrome in Children. , 2017, Journal of the American Society of Nephrology : JASN.

[31]  A. Philippakis,et al.  International Cooperation to Enable the Diagnosis of All Rare Genetic Diseases , 2017, American journal of human genetics.

[32]  O. Gribouval,et al.  Low renal but high extrarenal phenotype variability in Schimke immuno-osseous dysplasia , 2017, PloS one.

[33]  Marco Roos,et al.  The RD-Connect Registry & Biobank Finder: a tool for sharing aggregated data and metadata among rare disease researchers , 2018, European Journal of Human Genetics.

[34]  Tudor Groza,et al.  The Human Phenotype Ontology in 2017 , 2016, Nucleic Acids Res..

[35]  Christopher P Austin,et al.  ‘IRDiRC Recognized Resources': a new mechanism to support scientists to conduct efficient, high-quality research for rare diseases , 2016, European Journal of Human Genetics.

[36]  P. Holmans,et al.  Huntington’s disease blood and brain show a common gene expression pattern and share an immune signature with Alzheimer’s disease , 2017, Scientific Reports.

[37]  Christine M. Cutillo,et al.  Future of Rare Diseases Research 2017–2027: An IRDiRC Perspective , 2017, Clinical and translational science.

[38]  Christine M. Cutillo,et al.  Progress in Rare Diseases Research 2010–2016: An IRDiRC Perspective , 2017, Clinical and translational science.